A022 on-demand oral treatment with kvd900 for hae attacks achieves rapid exposure and improves patient outcomes

Bernstein, J., Li, H., Yea, C. et al. (5 more authors) (2021) A022 on-demand oral treatment with kvd900 for hae attacks achieves rapid exposure and improves patient outcomes. In: 2021 Annual Scientific MeetingAmerican College of Allergy, Asthma & Immunology, 04-08 Nov 2021, New Orleans, Louisiana.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
  • Bernstein, J.
  • Li, H.
  • Yea, C.
  • Maetzel, A.
  • Audhya, P.
  • Williams, P.
  • Banerji, A.
  • Riedl, M.
Dates:
  • Published: 4 November 2021
  • Published (online): 4 November 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Oct 2024 10:17
Last Modified: 07 Oct 2024 10:17
Published Version: https://www.sciencedirect.com/science/article/pii/...
Status: Published
Identification Number: 10.1016/j.anai.2021.08.024
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)